Continuation of research and development activities
First written in FY2017-Q1. 27 of 31 entries say "Restated". Latest entry: 2026-07-02.
115 other companies' latest entry also says "Advanced".
- 2026-07-02AdvancedGeneral Meetings of Shareholders
「Examples include thermoelectric power generation, hydrogen production and storage technologies, gallium nitride (GaN) related to next-generation semiconductors, and lithium-ion battery packs for transport and handling carts.」
The specific R&D targets included thermoelectric power generation, hydrogen, GaN and lithium-ion batteries. - FY2026AdvancedAnnual report
「We are also developing and commercializing products such as valves and manifolds for data-center servers. For valves, the first mass-production units were delivered in September 2025.」
R&D expenses were ¥2,712 million, and progress reached delivery of the first mass-production units of data-center valves, in addition to customer evaluation of heat exchangers. - FY2026-H1RestatedAnnual report
「The amount spent on R&D activities across the Group during the current consolidated interim period was ¥1,221 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D expenses of ¥1,221 million were recorded, and no material changes in R&D activities were reported. - FY2025AdvancedAnnual report
「In Thermal Solutions, prototype heat exchangers for electric vehicles and rechargeable batteries for renewable energy applications have been delivered to customers and are currently being evaluated. Further improvements are being made based on customer feedback to enhance product maturity.」
R&D expenses were ¥2,655 million, and progress was made from development to evaluation and preparation for mass production, including the delivery and customer evaluation of heat exchanger prototypes and orders for data-center valves and the establishment of a mass-production system. - FY2025-H1RestatedAnnual report
「The amount spent on R&D activities across the Group during the current consolidated interim period was ¥1,271 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D expenses of ¥1,271 million were recorded, and no material changes in the status of R&D activities were reported. - FY2024-Q3RestatedAnnual report
「The amount spent on R&D activities across the Group during the third quarter of the current consolidated cumulative period was ¥1,451 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D expenses of ¥1,451 million were recorded, and no material changes in R&D activities were reported. - FY2024-Q2RestatedAnnual report
「The amount spent on R&D activities across the Group during the second quarter of the current consolidated cumulative period was ¥914 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D expenses of ¥914 million were recorded, and no material changes in the status of R&D activities were reported. - FY2024-Q1RestatedAnnual report
「The amount spent on R&D activities across the Group during the first quarter of the current consolidated cumulative period was ¥430 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D expenses of ¥430 million were recorded, and no material changes in R&D activities were reported. - FY2023-Q3RestatedAnnual report
「The amount spent on R&D activities across the Group during the third quarter of the current consolidated cumulative period was ¥1,523 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D activities continued, and cumulative nine-month R&D expenses reached ¥1,523 million. No material changes were reported in the status of those activities. - FY2023-Q2RestatedAnnual report
「The amount spent on R&D activities across the Group during the second quarter of the current consolidated cumulative period was ¥967 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D activities continued, with cumulative first-half R&D expenses of ¥967 million disclosed along with the absence of material changes in the status of those activities. - FY2022RestatedAnnual report
「Our primary policy is to conduct R&D based on our corporate philosophy and mission of working for the safety and security of stakeholders and environmental conservation. In addition, we are pursuing the development of new technologies to achieve the medium-term management policy announced in May 2021.」
R&D focused on safety and security and environmental conservation continued, and the development of new technologies to achieve the medium-term management policy progressed. R&D expenses were ¥1,736 million. - FY2022-Q2RestatedAnnual report
「The amount spent on R&D activities across the Group during the second quarter of the current consolidated cumulative period was ¥795 million. There were no material changes in the status of the Group's R&D activities during the period.」
The company reported no material changes in R&D activities and disclosed cumulative first-half R&D expenses of ¥795 million. - FY2022-Q1RestatedAnnual report
「The amount spent on R&D activities across the Group during the first quarter of the current consolidated cumulative period was ¥287 million. There were no material changes in the status of the Group's R&D activities during the period.」
There were no material changes in R&D activities, and R&D expenses were ¥287 million. - FY2021RestatedAnnual report
「Our primary policy is to conduct R&D based on our corporate philosophy and mission of working for the safety and security of stakeholders and environmental conservation. In addition, we are pursuing the development of new technologies to achieve the medium-term management policy announced in May 2021.」
R&D focused on safety and security and environmental conservation continued, with the development of new technologies to achieve the medium-term management policy added to the scope. R&D expenses were ¥1,282 million. - FY2021-Q2RestatedAnnual report
「The amount spent on R&D activities across the Group during the second quarter of the current consolidated cumulative period was ¥620 million. There were no material changes in the status of the Group's R&D activities during the period.」
There were no material changes in R&D activities, and cumulative first-half R&D expenses were ¥620 million. - FY2021-Q1RestatedAnnual report
「The amount spent on R&D activities across the Group during the first quarter of the current consolidated cumulative period was ¥286 million. There were no material changes in the status of the Group's R&D activities during the period.」
There were no material changes in R&D activities, and cumulative quarterly R&D expenses were ¥286 million. - FY2020-Q3RestatedAnnual report
「The amount spent on R&D activities across the Group during the third quarter of the current consolidated cumulative period was ¥807 million. There were no material changes in the status of the Group's R&D activities during the period.」
The absence of material changes in R&D activities was confirmed, and cumulative nine-month R&D expenses of ¥807 million were disclosed. - FY2020-Q2RestatedAnnual report
「The amount spent on R&D activities across the Group during the second quarter of the current consolidated cumulative period was ¥495 million. There were no material changes in the status of the Group's R&D activities during the period.」
There were no material changes in R&D activities, and cumulative first-half R&D expenses were ¥495 million. - FY2020-Q1RestatedAnnual report
「The amount spent on R&D activities across the Group during the first quarter of the current consolidated cumulative period was ¥277 million. There were no material changes in the status of the Group's R&D activities during the period.」
There were no material changes in R&D activities, and cumulative quarterly R&D expenses were ¥277 million. - FY2019RestatedAnnual report
「Based on our corporate philosophy, our primary R&D policy is to work for the safety and security of stakeholders and environmental conservation, and we are pursuing the development of highly reliable new products and technologies that help reduce environmental impact.」
R&D focused on safety and security, environmental conservation, and high reliability continued. Total R&D expenses were ¥1,018 million. - FY2019-Q3RestatedAnnual report
「The amount spent on R&D activities across the Group during the third quarter of the current consolidated cumulative period was ¥788 million. There were no material changes in the status of the Group's R&D activities during the period.」
There were no material changes in R&D activities, and cumulative nine-month R&D expenses were ¥788 million. - FY2019-Q2RestatedAnnual report
「The amount spent on R&D activities across the Group during the second quarter of the current consolidated cumulative period was ¥553 million. There were no material changes in the status of the Group's R&D activities during the period.」
There were no material changes in R&D activities, and cumulative first-half R&D expenses were ¥553 million. - FY2019-Q1RestatedAnnual report
「The amount spent on R&D activities across the Group during the first quarter of the current consolidated cumulative period was ¥312 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D activities continued, with cumulative quarterly R&D expenses of ¥312 million disclosed, along with the absence of material changes in the status of those activities. - FY2018-Q3RestatedAnnual report
「The amount spent on R&D activities across the Group during the third quarter of the current consolidated cumulative period was ¥1,077 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D activities continued, with cumulative nine-month R&D expenses of ¥1,077 million disclosed, along with the absence of material changes in the status of those activities. - FY2018-Q2RestatedAnnual report
「The amount spent on R&D activities across the Group during the second quarter of the current consolidated cumulative period was ¥695 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D activities continued, with cumulative first-half R&D expenses of ¥695 million disclosed, along with the absence of material changes in the status of those activities. - FY2018-Q1RestatedAnnual report
「The amount spent on R&D activities across the Group during the first quarter of the current consolidated cumulative period was ¥365 million.」
The continuation of R&D activities is disclosed together with the amount spent. - FY2018-Q1RestatedAnnual report
「The amount spent on R&D activities across the Group during the first quarter of the current consolidated cumulative period was ¥365 million. There were no material changes in the status of the Group's R&D activities during the period.」
There were no material changes in R&D activities, and R&D expenses for the quarter were ¥365 million. - FY2017RestatedAnnual report
「Based on our corporate philosophy, our primary R&D policy is to work for the safety and security of stakeholders and environmental conservation, and we are pursuing the development of highly reliable new products and technologies that help reduce environmental impact. Total R&D expenses for the current consolidated fiscal year were ¥2,936 million, and R&D expenses by segment were as follows.」
R&D continued, with the development of new products and technologies focused on safety and security, environmental conservation, and high reliability. Full-year R&D expenses were ¥2,936 million. - FY2017-Q3RestatedAnnual report
「The amount spent on R&D activities across the Group during the third quarter of the current consolidated cumulative period was ¥2,155 million.」
R&D activities continued, and cumulative nine-month R&D expenses are disclosed. - FY2017-Q2RestatedAnnual report
「The amount spent on R&D activities across the Group during the second quarter of the current consolidated cumulative period was ¥1,454 million.」
R&D activities continued, and cumulative first-half R&D expenses are disclosed. - FY2017-Q1First statedAnnual report
「The amount spent on R&D activities across the Group during the first quarter of the current consolidated cumulative period was ¥722 million.」
R&D expenses for the cumulative quarterly period are disclosed.